Grünenthal’s USD350 Million Acquisition Of Exclusive Rights To Crestor

Paolo Bossi Europe, Europe Legal Chronicle

Allen & Overy advised Grünenthal on the deal. Grünenthal acquired the European rights (excluding Spain and the UK) to Crestor (rosuvastatin) and its associated brands for…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here